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Abstract
Background: Transcription factors (TFs) are effectors of cell signaling pathways that regulate gene expression. TF
networks are highly interconnected; one signal can lead to changes in many TF levels, and one TF level can be
changed by many different signals. TF regulation is central to normal cell function, with altered TF function being
implicated in many disease conditions. Thus, measuring TF levels in parallel, and over time, is crucial for
understanding the impact of stimuli on regulatory networks and on diseases.
Results: Here, we report the parallel analysis of temporal TF level changes due to multiple stimuli in distinct cell
types. We have analyzed short-term dynamic changes in the levels of nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-kB), signal transducer and activator of transcription 3 (Stat3), cAMP response element-binding
protein (CREB), glucocorticoid receptor (GR), and TATA binding protein (TBP), in breast and liver cancer cells after
tumor necrosis factor-alpha (TNF-α) and palmitic acid (PA) exposure. In response to both stimuli, NF-kB and CREB
levels were increased, Stat3 decreased, and TBP was constant. GR levels were unchanged in response to TNF-α
stimulation and increased in response to PA treatment.
Conclusions: Our results show significant overlap in signaling initiated by TNF-α and by PA, with the exception
that the events leading to PA-mediated cytotoxicity likely also include induction of GR signaling. These results
further illuminate the dynamics of TF responses to cytokine and fatty acid exposure, while concomitantly
demonstrating the utility of parallel TF measurement approaches in the analysis of biological phenomena.
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Background
Proper cellular responses to their microenvironments
are crucial for cell and tissue homeostasis. Abnormal
cellular signaling can lead to diseases such as cancer and
diabetes [1–5]. Improved understanding of signaling has
led to improvements in disease diagnosis, the under-
standing of developmental processes, and the engineer-
ing of artificial tissues [6–8]. In fact, recent advances in
cell signaling pathway analysis have led to the advent of
a new field of study, systems biology [9]. Systems biology
relies on vast amounts of data that can be generated
from the various “omics” techniques. These data repre-
sent the results of cell signal transduction and would be
complemented by parallel measurements of the levels of
transcription factors, the upstream mediators of cellular
signaling.
Transcription factors (TFs) are responsible for altering
the cell state in response to stimuli by changing the
transcription rates of their targeted genes. They interact
with specific sites on genomic DNA, often recruiting
other co-factors to the location, resulting in activation
or repression of the corresponding genes. Analysis of
cell signaling responses to stimuli is complicated by the
fact that TFs generally control several genes, most genes
are controlled by multiple TFs, and any given stimulus
can result in the activation of multiple TFs [10–12].
Moreover, TF levels must change in response to a
stimulus but, in most cases, must then return to base-
line levels to avoid long-term perturbation of cellular
function [13, 14]. The TFs that control genes involved
in the rapid response to stimuli are often present in the
cytoplasm in an inactive state, translocated to the nu-
cleus after activation, and then destroyed or trafficked
out of the nucleus to halt their function [15–18]. Thus,
tracking TF activities requires analysis across many di-
mensions, including activation status, subcellular loca-
tion, and time. With an estimated 2000 TFs in humans,
profiling the levels of active TFs is a dynamic and com-
plex task.
To address this challenge, we and others are develop-
ing quantitative, sensitive, parallel techniques for meas-
urement of TF levels [19–22]. We have previously
demonstrated parallel measurements of TFs in extracts
from breast cancer cells using our magnetic bead-based
assay [23]. Our approach aims to simplify measuring
TFs in parallel, by detecting TF-bound dsDNA, rather
than the TF itself. In this way, a challenging task, parallel
protein detection, is reformulated into a relatively
straightforward task, parallel nucleic acid detection. In
this study, we have expanded the number of TFs ana-
lyzed and applied our method to the kinetic analysis of
cellular responses to multiple stimuli, specifically to cy-
tokines (tumor necrosis factor-α, TNF-α) and saturated
fatty acids (palmitic acid, PA).
Methods
DNA probe design and radiolabeling
Detailed design information and probe sequences are
listed in the (Additional file 1: Table S1). ssDNAs were
purchased from Integrated DNA Technologies (Coralville,
IA). Probes were generated by hybridization of equimolar
amounts of complementary ssDNAs in 1× STE buffer
(10 mM Tris, 100 mM NaCl, and 1 mM EDTA), heating
to 95 °C for 5 min, followed by incubation at room
temperature for 1 h. After hybridization, dsDNA probes
were 5′-radiolabeled with 10 pmoles of [γ-33P] ATP using
T4 polynucleotide kinase (New England Biolabs, Ipswich,
MA). Radiolabeled DNA probes were purified from un-
incorporated label with G-25 Sephadex columns (Roche
Applied Science; Indianapolis, IN).
Cell culture
Our experiments were conducted with two different cell
lines, HepG2 (human hepatocellular carcinoma, ob-
tained from ATCC) and MDA-MB-231 (human breast
adenocarcinoma, generously provided by Kathleen Gallo,
Department of Physiology, Michigan State University).
HepG2 cells were cultured in Dulbecco’s Modified Eagle
Medium (Life Technologies; Grand Island, NY) supple-
mented with 10 % fetal bovine serum (Life Technologies;
Grand Island, NY), 100 μg/mL streptomycin (Life Tech-
nologies; Grand Island, NY) and 100 U/mL penicillin
(Life Technologies; Grand Island, NY) in a humidified
incubator at 37 °C and 5 % CO2. For TNF-α treatments,
cells were grown to 90 % confluence in 6-well plates and
then treated with 50 ng/ml recombinant human TNF-α
(R&D Systems; Minneapolis, MN) for periods of 0.5, 1,
2, 4 and 24 h. Control cells received fresh media without
TNF-α. For palmitic acid treatments, cells were grown
to 90 % confluence in 6-well plates and then treated with
media containing 0.7 mM palmitic acid (Sigma; St.
Louis, MO) complexed with 2 % (w/v) fatty acid free
BSA (US Biologicals; Salem, MA) for 0.5, 1, 2, 4, 16, and
24 h. Control cells were grown in media containing 2 %
BSA for the same time periods.
MDA-MB-231 cells were cultured in Dulbecco’s Modi-
fied Eagle Medium (Life Technologies; Grand Island, NY)
with 10 % fetal bovine serum, 2 mM glutamine (Life Tech-
nologies; Grand Island, NY), 100 μg/mL streptomycin, and
100 U/mL penicillin. Cells were maintained in a humidi-
fied incubator at 37 °C and 10 % CO2 as described [24].
For TNF-α treatments, cells were grown to 90 % conflu-
ence in 6-well plates and then treated with 50 ng/ml re-
combinant human TNF-α for periods of 0.5, 1, 2, 4 and
24 h. Control cells received fresh media without TNF-α.
Nuclear extraction
For HepG2 cells, nuclear extraction was performed as
described [25]. Briefly, after washing the cells with PBS,
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cells were resuspended and allowed to swell in five times
the packed cell volume (PCV) of ice cold buffer (10 mM
HEPES (pH = 7.9) (Sigma; St. Louis, MO), 10 mM KCl,
0.1 mM EDTA, freshly added protease inhibitors
(complete mini EDTA free cocktail tablets, Roche), and
phosphatase inhibitors (phosphatase inhibitor cocktail,
Sigma)) for 15 min. After adding 10 % NP-40 solution to
a final concentration of 0.5 % (v/v), cells were vortexed
for 20 s, and nuclear pellets were collected by centrifu-
gation at 13,000 g for 1 min at 4 °C. Nuclear pellets were
washed three times with buffer (same as above) and re-
suspended in 1×PCV of ice cold buffer (20 mM HEPES
pH 7.9, 0.4 M NaCl, 1 mM EDTA, freshly added prote-
ase inhibitors (complete mini EDTA free cocktail tablets,
Roche), and phosphatase inhibitors (phosphatase inhibi-
tor cocktail, Sigma)). Pellets were shaken for 15 min,
and nuclear extracts were obtained by centrifugation at
13,000 g for 15 min at 4 °C. The total protein concentra-
tion in all extracts was measured by BCA Protein Assay
kit (Thermo Scientific Pierce; Rockford, IL).
For MDA-MB-231 cells, nuclear extraction was per-
formed as described [26]. Briefly, after washing the cells
with PBS, the cells were trypsinized and allowed to swell
in buffer (10 mM HEPES (pH = 8.0), 1.5 mM MgCl2,
10 mM KCl, protease inhibitor (complete mini EDTA
free cocktail tablets, Roche)) on ice for 15 min. The cells
were then lysed with 15 strokes of a 25-gauge, 5/8 inch
needle, and the nuclear pellets were collected by centri-
fugation at 12,000 g for 15 min. Nuclear pellets were re-
suspended and incubated in a second buffer (20 mM
HEPES (pH = 8.0), 1.5 mM MgCl2, 25 % glycerol,
420 mM NaCl, 0.2 mM EDTA (pH = 8.0), protease inhibi-
tor) on ice for 30 min. After incubation, nuclear extracts
(supernatants) were obtained following centrifugation at
12,000 g for 5 min.
It should be noted that complete separation of nuclear
and cytoplasmic extracts is crucial for accurate TF ana-
lyses. High fidelity separations preclude latent TFs in the
cytoplasmic fraction from giving a false positive signal
for the nuclear extracts [27]. To assess nuclear/cytoplas-
mic separation, we conducted western blots for TBP
(nuclear protein) and GAPDH (principally cytoplasmic
protein) (Additional file 2: Figure S1).
TF biotinylation
Nuclear extracts were chemically biotinylated by EZ-
Link-Iodoacetyl-PEG2-biotin (Thermo Scientific Pierce;
Rockford, IL), according to the manufacturer’s instructions.
Nuclear extracts were mixed with EZ-Link-Iodoacetyl-
PEG2-biotin in reaction buffer (50 mM Tris–HCl, 5 mM
EDTA, pH 8.0) at RT for 90 min. Biotinylated TFs were
purified with G-50 Sephadex columns (Roche Applied
Science; Indianapolis, IN). Sephadex columns were
washed three times with PBS prior to use.
Magnetic bead-based TF quantification
TFs were measured according to our established tech-
nique [23]. Biotin labeled TFs were immobilized on
streptavidin-coated magnetic beads (Dynal/Invitrogen;
Oslo, Norway) by incubation at RT for 20 min in 1×
PBS. After applying a magnet, the supernatant was re-
moved and the TF-bound beads recovered. Following
three washes, the TF-loaded beads were mixed with
dsDNA probes in binding buffer for 20 min at RT. The
supernatant was collected by applying the magnet again,
and the beads were washed twice with washing buffer
(0.02 % Tween 20 in water) with the supernatants col-
lected after each wash step.
Scintillation counting
For single TF measurements, the technique was per-
formed using one radiolabeled dsDNA probe while all
other probes were unlabeled. After binding to the TF-
loaded beads and washes to remove non-specifically
bound probes, the beads were resuspended in 50 μl of
water and then mixed with 10 ml Safety Solve High
Flash Point Scintillation Cocktail (Research Products
International Corporation; Mount Prospect, IL). The sig-
nal from all fractions (supernatant, wash 1, wash 2, and
beads) was measured, and the percentage of the signal
retained on the beads was calculated. All signals were
normalized to control to account for decay in the radio-
label on the probe.
Electrophoresis readout
For parallel TF measurements, dsDNA probes were
bound to the TF-loaded beads. After washes, the beads
were resuspended in 1×TBE and heated at 95 °C for
15 min to elute the retained DNA. A magnet was ap-
plied and the supernatant collected. Eluted DNA probes
(1 μl of the 25 μl) were mixed with universal primers
(300 nM) and amplified for 20 cycles with Taq DNA
Polymerase (New England Biolabs; Ipswich, MA) in
50 μl reactions. The PCR program was: 95 °C for 30 s
(melting), 61 °C for 30 s (annealing), and 72 °C for 10 s
(extension). 12 μl of PCR product was mixed with 4 μl
of gel loading buffer, and 14 μl was loaded onto native
4–12 % TBE gels. Gels were run at 300 V for 30 min on
ice, stained with SYBR Gold (Invitrogen; Carlsbad, CA),
and visualized in a ChemiDoc XRS System (Bio-Rad;
Hercules, CA). Band intensities were quantified by
QuantityOne software. For normalization, each signal
was normalized to an internal standard included in each
PCR reaction. The internal standard included the univer-
sal primer sites but did not contain a TF binding site.
This accounted for run-to-run differences in PCR effi-
ciency and gel exposure. After signals were normalized
to the internal standard, the ratio of treated to control
was calculated. We have previously validated the
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quantitative binding and release of probes from the
TFs bound to the beads and all other steps prior to
PCR [23].
TF measurements by EMSA
Biotinylated TFs were mixed with dsDNA probes (one
probe radiolabeled, the rest unlabeled) in a 20 μl reac-
tion volume of binding buffer (10 mM Tris–HCl, 1 mM
MgCl2, 0.5 mM EDTA, 0.5 mM DTT, 50 mM NaCl,
1 mM CaCl2, 0.2 mM KCl, 10 mM ZnCl2, 4 % glycerol,
20 mM acetic acid, 0.025 μg/μL poly (dI-dC)) for 30 min
at RT. Biotinylated TF concentrations were measured by
Bradford assay with 2 μg of protein loaded per assay.
15 μl of the binding reaction were mixed with 5 μl of gel
loading buffer, and 18 μl was loaded onto native 4–12 %
TBE gels. Gels were run at 300 V for 30 min on ice,
dried, and detected by phosphorimaging using the Storm
860 (GE Healthcare; Pittsburgh, PA). Band intensities
were quantified by QuantityOne software. A representa-
tive image is provided in the (Additional file 3: Figure S2).
Statistical analyses
All experiments were performed at least 3 times. For gel
images, representative results are shown. All error bars
show the mean +/− SD value of experiments performed.
Two-way student t-test was used to evaluate statistical
significance of values compared to control samples. The
t-test was conducted as follows: a pooled variance was
calculated for all time points for a given TF to account
for the distribution of variances across the different sam-
ples. A t-statistic was calculated from the degrees of
freedom for each TF and was used to build a 95 % confi-
dence interval about the mean for each TF at each time
point. Significance relative to normalized controls was
determined by whether the value of 1 did (not significant)
or did not (significant) fall within the 95 % confidence
interval. This analysis was developed in consultation
MSU’s Center for Statistical Training and Consulting
(CSTAT).
Results and discussion
Having previously demonstrated applicability of our ap-
proach to parallel measurement of TFs [23], we sought
to apply the technique to furthering our understanding
of biological signaling kinetics while also demonstrating
use of the technique for measuring a broader array of
TFs in parallel. We chose to examine cytokine stimula-
tion and fatty-acid exposure of cells as stimuli and de-
signed our panel of TFs according to our expectations
about which pathways could be activated by these stim-
uli. In addition, we tested our technique using extracts
from two unique cell types to demonstrate the applic-
ability of the method to different cell systems and to
examine the commonalities and differences in response
among the systems and stimuli.
TF measurements in MDA-MB-231 breast cancer cells
stimulated with TNF-α
We first examined the changes in nuclear TF levels asso-
ciated with TNF-α stimulation of MDA-MB-231 breast
cancer cells. These experiments were intended to serve
as an initial validation of our larger set of TF measure-
ments. For these experiments, the levels of four different
TFs were measured in parallel with respect to treatment
time (Fig. 1). These TFs were nuclear factor kappa-light-
chain-enhancer of activated B cells (NF-kB), signal trans-
ducer and activator of transcription 3 (Stat3), gluco-
corticoid receptor (GR), and TATA binding protein
(TBP). For measurements of individual TFs (in which we
only tested NF-kB, Stat3, and TBP), our results showed
an increase in nuclear NF-kB levels after TNF-α stimula-
tion, with levels peaking at 1 h after stimulation (Fig. 1a).
NF-kB levels returned to baseline after approximately
4 h, remaining at or near baseline levels for the remain-
der of the experiment. On the other hand, Stat3 levels
decreased after 0.5 h, returning to baseline levels after
2 h. Our expected control TF, TBP, showed no signifi-
cant change over the course of the experiment. To con-
firm our results, we performed electrophoretic mobility
shift assays (EMSAs) on each of the samples. Agreement
was seen between the EMSA (Fig. 1b) and measure-
ments by our method (Fig. 1c) in the data trends (in-
creases and decreases in TF levels) and generally in the
magnitude of the changes, as well.
Our objective is to expand the technique to detection
of hundreds of TFs in parallel with a high throughput
technique such as parallel sequencing. For our current
scale of 4 TFs in parallel, a PCR-based readout was ap-
plied as a proxy for such readouts. Each dsDNA probe
was designed to include universal sense and antisense
primer sequences and to yield a PCR product of unique
length following amplification. To accomplish this, we
included different numbers of binding sequence repeats
for some TFs (Additional file 1: Table S1). In our experi-
ments, eluted DNAs from magnetic beads were PCR
amplified with universal primers for 20 cycles, to achieve
a semi-quantitative PCR readout. For all TFs, our single
protein measurements with EMSA and scintillation
counting correlated well with the levels measured in par-
allel (Fig. 1d and e). In all detection techniques, NF-kB
levels were increased within 0.5 h and returned to base-
line after 4 h. In contrast, Stat3 levels decreased and re-
covered over the same time period. GR levels were
unchanged with TNF-α treatment. This was our expect-
ation based upon prior work in muscle cells [28]. The
changes in NF-kB and STAT levels agree with previously
published reports examining the responses of these TFs
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to TNF-α stimulation [29, 30], though these were mea-
sured at a single timepoint. Our kinetic data demon-
strate that TF levels in the nucleus can change rapidly
both in the initiation of the response and in the return
to baseline levels.
TF measurements in HepG2 cells stimulated with TNF-α
To test the feasibility of our assay with different cell types,
we measured TF levels in HepG2 cells. cAMP response
element-binding protein (CREB) was included in this set
of measurements. We and other have previously studied
the effects of TNF-α on these TFs [31, 32]. As with the
breast cancer cell experiments, individual TF levels were
detected with scintillation counting and EMSA (Fig. 2a,
b), while multiple TFs were detected by our parallel PCR
readout (Fig. 2d). Results from the three different tech-
niques correlated well, showing NF-kB and CREB levels





Fig. 1 Quantification of TF levels in nuclear extracts of MDA-MB-231 cells after TNF-α stimulation. a Single TF detection by bead assay. The percentage of
radiolabeled TF probe remaining on the beads (relative to signal that did not bind or was washed from the beads) was calculated. Fold changes relative
to control are shown. (n = 3, * indicates p < 0.05). b Single TF detection by EMSA. The fractions of bound and unbound DNA probe were quantified,
and the fraction of bound signal was calculated relative to the total signal from the lane. Fold changes relative to control are shown. (n = 3, * indicates
p < 0.05). c Correlation between detection by bead assay and EMSA. The 1:1 line (blue) is included for reference. d Parallel TF detection by bead assay.
Signals were normalized with respect to an internal standard and then the ratio with respect to control was calculated. (n = 3, * indicates p < 0.05).
e Correlation of single and parallel bead assay measurements. The 1:1 line (blue) is included for reference
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later than NF-kB (Fig. 2c and e). Over a similar timeframe,
Stat3 levels decreased and also returned to baseline. After
4 h, all measured TF levels returned to control levels. TBP
and GR levels were unchanged during the measurement
period. These results align with those from the breast can-
cer cell experiments (Fig. 1).
In hepatocytes, TNF-α has been shown to initiate sev-
eral different responses, including cytotoxicity [33].
C D
E
Fig. 2 Quantification of TF levels in nuclear extracts of HepG2 cells after TNF-α stimulation. a Single TF detection by bead assay. The percentage
of radiolabeled TF probe remaining on the beads (relative to signal that did not bind or was washed from the beads) was calculated. Fold
changes relative to control are shown. (n = 3, * indicates p < 0.05). b Single TF detection by EMSA. The fractions of bound and unbound DNA
probe were quantified, and the fraction of bound signal was calculated relative to the total signal from the lane. Fold changes relative to control
are shown. (n = 3, * indicates p < 0.05). c Correlation between detection by bead assay and EMSA. The 1:1 line (blue) is included for reference. d
Parallel TF detection by bead assay. Signals were normalized with respect to an internal standard and then the ratio with respect to control was
calculated. (n = 3, * indicates p < 0.05). e Correlation of single and parallel bead assay measurements. The 1:1 line (blue) is included for reference
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However, hepatocytes are capable of resisting the cyto-
toxic effects of TNF-α by activating NF-kB [34]. Add-
itionally, recent studies have suggested that TNF-α
signaling can activate the IKK/JNK pathway [32, 35],
which, in turn, enhances CREB activity [36, 37]. Both
NF-kB and CREB activate transcription of anti-apoptotic
and cell proliferation genes [20, 38]. In line with this
possible defensive response, we found rapid activation of
both TFs by TNF-α.
The reduced nuclear levels of Stat3 may suggest a rapid
export/degradation of nuclear Stat3 or a reduction in the
rate of translocation from the cytoplasm to the nucleus. It
is known that Stat3 localized to the cytoplasm may inter-
act with protein kinase R (PKR) and inhibit its phosphor-
ylation activity [39]. PKR inhibits translation initiation and
induces apoptosis via the FADD-dependent Caspase 8
pathway [40]. Thus, lower levels of Stat3 in the nucleus, if
accompanied by concomitant increases in cytoplasmic
Stat3, may suggest a possible anti-apoptotic effect medi-
ated by PKR repression.
For additional validation of our measured responses,
we also compared the TF measurements to western blot-
ting of each TF, with qualitative but not quantitative
agreement (Additional file 4: Figure S3). Western blot-
ting is a technique that measures the total quantity of
TF protein, while our approach and EMSA specifically
measure the quantity of active TF (as defined by its abil-
ity to bind its dsDNA recognition sequence). Since west-
ern blotting consistently showed elevated signals relative
to the other approaches, this suggests that either TFs are
being inactivated during sample preparation, which
seems unlikely given the activity of the remaining pro-
teins, or that a large fraction (~50 %) of the TF mole-
cules that are present in the nucleus are inactive prior to
destruction or trafficking out of the nucleus [41]. Our
data also demonstrate how important kinetic measure-
ments of TF levels can be to understanding biological
processes. For our TFs, measurements at 24 h alone
would have shown no response, hiding the early events
in response to the stimulus that likely contribute to
downstream changes in cellular function.
TF measurements in HepG2 cells stimulated with palmitic
acid
In recent years, we and others have focused on the cyto-
toxic effects of FFAs on hepatocytes [42, 43]. However,
the signaling pathways associated with palmitic acid
(PA) exposure are not well-established. Thus, we wanted
to address which TFs of our analytical set are involved in
the cellular response to PA exposure. Prior work had
identified a role for NF-kB and CREB [44]. Our particu-
lar interest in GR is two-fold. First, GR was shown to in-
crease activated CREB levels [45], and CREB can act
with GR to regulate genes where their binding sites are
within 90 bp of each other [46]. As above, TF expression
levels were measured by scintillation counting or EMSA
for individual TFs, or PCR for TFs in parallel (Fig. 3) (A
representative image of the parallel PCR readout is
shown in the Additional file 5: Figure S4). Our data con-
sistently show that NF-kB activity increased and reached
a maximum at 30 min, then returned to baseline by 2 h,
with a similar pattern observed with CREB. As with our
TNF-α studies, nuclear Stat3 levels decreased by 30 min
and returned to basal levels by 2 h. Importantly, GR
levels were increased by PA treatment, peaking at 1 h.
TBP levels were unchanged as expected.
These data show that HepG2 cells respond to PA
treatment by dynamic changes in the trafficking of these
TFs into or out of the nucleus. Of the TFs we measured,
NF-kB was most rapidly activated, followed soon after
by CREB and GR. The increased activities of NF-kB and
CREB in response to elevated free fatty acids is in agree-
ment with prior studies [44]. Given that elevated levels
of PA are cytotoxic to HepG2 cells [47], this response
suggests that NF-kB and CREB are activated to initiate
an anti-apoptotic response to this stimulus, as in the
TNF-α experiments.
Comparison of TNF-α and PA responses
The NF-kB, CREB and Stat3 responses of HepG2 cells
to palmitic acid and TNF-α are similar, indicating that
similar pathways are activated by each stimulus. It has
already been shown that circulating and liver levels of
TNF-α are elevated in non-alcoholic fatty liver disease
(NAFLD) [48, 49]. Additionally, free fatty acids have
been shown to elevate TNF-α expression [50]. It is un-
clear if TNF-α signaling is associated with the response
to PA that we have measured, given the short time scales
over which we detect significant changes in TF levels. It
may be that the similarity in the responses is related to
existing crosstalk between the two pathways.
Intriguingly, GR responds differently between the
TNF-α and PA stimulated experiments. Currently, no
data support a role of GR in mediating PA-induced cyto-
toxicity. However, it has been shown that elevated levels
of glucocorticoids may be associated with pathogenesis
of NAFLD [51]. Also, in previous studies, GR has been
shown to significantly enhance activated CREB levels
[44], with both being increased in our results. GR and
CREB are known to synergistically activate expression of
certain genes, e.g., phosphoenolpyruvate carboxykinase
(PEPCK), somatostatin, and even GR itself [52, 53]. Im-
portantly, activation of PEPCK by palmitic acid was ob-
served with HepG2 cells previously [54]. It has also been
shown that there is crosstalk between GR and CREB in
regulating neuronal genes [55]. Taken together, our
results and the literature suggest that genes regulated by
GR (and perhaps particularly those co-regulated by
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CREB and GR) might be important in the cellular re-
sponse to saturated fatty acid (palmitic acid) exposure.
Stat3 may also respond differently to TNF-α and PA.
While the early downregulation of Stat3 levels is consist-
ent between the stimuli, in some of the TNF-α analyses,
Stat3 levels at 4 h are slightly elevated (e.g., Figs. 1b, 2a).
This may be a result of a feedback mechanism to restore
Stat3 to basal levels. Additional timepoints between 4 h
and 24 h may have clarified whether the observed in-
crease in Stat3 was biologically meaningful.
Future development and experiments
In this work, we have shown that our assay can be ap-
plied to measure TF levels in parallel over time and is
useful for the analysis of TFs involved in cytokine and
fatty acid treatments of cultured cells. For both of our
C D
E
Fig. 3 Quantification of TF levels in nuclear extracts of HepG2 cells after palmitic acid treatment. a Single TF detection by bead assay. The
percentage of radiolabeled TF probe remaining on the beads (relative to signal that did not bind or was washed from the beads) was calculated.
Fold changes relative to control are shown. (n = 3, * indicates p < 0.05). b Single TF detection by EMSA. The fractions of bound and unbound
DNA probe were quantified, and the fraction of bound signal was calculated relative to the total signal from the lane. Fold changes relative to
control are shown. (n = 3, * indicates p < 0.05). c Correlation between detection by bead assay and EMSA. The 1:1 line (blue) is included for
reference. d Parallel TF detection by bead assay. Signals were normalized with respect to an internal standard and then the ratio with respect to
control was calculated. (n = 3, * indicates p < 0.05). e Correlation of single and parallel bead assay measurements. The 1:1 line (blue) is included
for reference
Bilgin et al. BMC Biotechnology  (2016) 16:62 Page 8 of 10
model systems, we used cancer cell lines with which we
have considerable experience. We acknowledge that the
responses we detected may not be universal across all hu-
man cell types but are nonetheless useful in demonstrat-
ing the ability of our method to detect changes in TF
levels. We believe that our assay can be used to profile
other TF pathways and to study early cellular responses.
We recognize that we only measured a limited number
of TFs in parallel and only over a 24 h time period. Subse-
quent work and redesign of the technique will focus on in-
clusion of late-acting TFs, whose expression level changes
would be expected after 8 h. Complementing our analyt-
ical approach with chromatin immunoprecipitation
(ChIP), either for individual TFs or in parallel, would fur-
ther our understanding of the downstream signaling that
results from the nuclear TFs we measure. This combin-
ation of early-acting and late-acting TFs would consider-
ably enhance the information provided by the technique
in analyzing biological systems. Combined with other par-
allel analytical techniques, our approach would contribute
to a more complete picture of TF regulation and signaling
in response to a variety of stimuli.
Conclusions
We have dynamically measured TF levels in response to
cytokine and palmitic acid treatments using our previously
developed assay. With our assay, NF-kB, CREB, Stat3, GR,
and TBP levels were successfully analyzed over 24 h. Our
assay can be further improved for profiling larger sets of
TFs and could contribute to explorations of cellular regu-
latory mechanisms, TF pathway mapping, and modeling
of dynamic signaling networks.
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